Amanote Research
Register
Sign In
Human Medicines European Public Assessment Report (EPAR): Duloxetine Lilly, Duloxetine, Neuralgia,Diabetic Neuropathies, Date of Authorisation: 08/12/2014, Revision: 4, Status: Authorised
Case Medical Research
doi 10.31525/cmr-cdebc6
Full Text
Open PDF
Abstract
Available in
full text
Date
July 25, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Human Medicines European Public Assessment Report (EPAR): Cymbalta, Duloxetine, Anxiety Disorders,Diabetic Neuropathies,Depressive Disorder, Major, Date of Authorisation: 17/12/2004, Revision: 26, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Palonosetron Hospira, Palonosetron, Nausea,Vomiting,Cancer, Date of Authorisation: 08/04/2016, Revision: 4, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Odomzo, Sonidegib, Carcinoma, Basal Cell, Date of Authorisation: 14/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Ivabradine Anpharm, Ivabradine, Angina Pectoris,Heart Failure, Date of Authorisation: 08/09/2015, Revision: 4, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Levetiracetam Sun, Levetiracetam, Epilepsy, Date of Authorisation: 14/12/2011, Revision: 11, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Pregabalin Accord, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Tadalafil Mylan, Tadalafil, Erectile Dysfunction, Date of Authorisation: 21/11/2014, Revision: 8, Status: Authorised
Case Medical Research
